1)Gilman MW, et al:Influence of heart rate on mortality among persons with hypertension;The Framingham Study. Am Heart J 125:1148-1154, 1993
2)日本高血圧学会治療ガイドライン作成委員会:高血圧治療ガイドライン2004,日本高血圧学会,2005
3)UK Prospective Diabetes Study Group:Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type2diabetes;UKPDS 39. Brit J Med 317:713-720, 1998
4)Bakris GL, et al:Metabolic effects of carvediol vs metoprolol in patients with type2diabetes mellitus and hypertension. JAMA 292:2227-2236, 2004
5)Wikstrand J, et al:Primary prevention with metoprolol in patients with hypertension;Mortality results from the MAPHY study. JAMA 259:1976-1982, 1998
6)Hansson L, et al:Randomized trial of old and new antihypertensive drugs in elderly patients;Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 354:1751-1756, 1999
7)Kario K, et al:Morning blood pressure surge and hypertensive cerebrovascular disease. Am J Hypertens 17:668-675, 2004
8)Kario K, et al:The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes;Evaluation using home-based blood pressure measurements. Clin Exp Hypertens 27:369-376, 2005
9)Anderson PE, et al:Effects of selective alfa1and beta1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity. J Hum Hypertens 8:219-226, 1994
10)Neaton JD, et al:Treatment of mild hypertension study;Final results. JAMA 270:713-724, 1993
11)Levy D, et al:Principal results of the hypertension and lipid trial (HALT);A multicenter study of doxazosin in patients with hypertension. Am Heart J 131:966-973, 1996
12)Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group:Diuretic versus alpha-blocker as first-step antihypertensive therapy;Final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).Hypertension 42:239-246, 2003
13)廣岡良隆:交感神経抑制薬の展望.日本臨牀 63:565-571, 2005
14)廣岡良隆:高血圧症の標的臓器障害と交感神経活動.血圧 12:668-672, 2005